nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocortisone—ABCB1—peripheral nervous system neoplasm	0.24	1	CbGaD
Hydrocortisone—ABCG2—Topotecan—peripheral nervous system neoplasm	0.0566	0.111	CbGbCtD
Hydrocortisone—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.0393	0.0769	CbGbCtD
Hydrocortisone—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.0389	0.0762	CbGbCtD
Hydrocortisone—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.0389	0.0762	CbGbCtD
Hydrocortisone—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0292	0.0572	CbGbCtD
Hydrocortisone—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.028	0.055	CbGbCtD
Hydrocortisone—ABCG2—Vincristine—peripheral nervous system neoplasm	0.0242	0.0474	CbGbCtD
Hydrocortisone—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.0225	0.0442	CbGbCtD
Hydrocortisone—ABCG2—Etoposide—peripheral nervous system neoplasm	0.0221	0.0434	CbGbCtD
Hydrocortisone—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0204	0.04	CbGbCtD
Hydrocortisone—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0204	0.04	CbGbCtD
Hydrocortisone—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.0179	0.035	CbGbCtD
Hydrocortisone—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.0179	0.035	CbGbCtD
Hydrocortisone—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.0151	0.0296	CbGbCtD
Hydrocortisone—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0142	0.0277	CbGbCtD
Hydrocortisone—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0134	0.0263	CbGbCtD
Hydrocortisone—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0123	0.0241	CbGbCtD
Hydrocortisone—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0122	0.024	CbGbCtD
Hydrocortisone—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0118	0.0231	CbGbCtD
Hydrocortisone—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0114	0.0223	CbGbCtD
Hydrocortisone—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00872	0.0171	CbGbCtD
Hydrocortisone—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00813	0.0159	CbGbCtD
Hydrocortisone—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00799	0.0157	CbGbCtD
Hydrocortisone—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00545	0.0107	CbGbCtD
Hydrocortisone—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00522	0.0102	CbGbCtD
Hydrocortisone—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00479	0.00938	CbGbCtD
Hydrocortisone—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00326	0.0064	CbGbCtD
Hydrocortisone—Drospirenone—BCHE—peripheral nervous system neoplasm	0.000506	0.236	CrCbGaD
Hydrocortisone—ANXA1—Peptide ligand-binding receptors—NTS—peripheral nervous system neoplasm	0.000494	0.0181	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.000471	0.0173	CbGpPWpGaD
Hydrocortisone—CYP3A5—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000458	0.0168	CbGpPWpGaD
Hydrocortisone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—peripheral nervous system neoplasm	0.000447	0.0164	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—NF1—peripheral nervous system neoplasm	0.000431	0.0158	CbGpPWpGaD
Hydrocortisone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—GNAS—peripheral nervous system neoplasm	0.000387	0.0142	CbGpPWpGaD
Hydrocortisone—Triamcinolone—BCHE—peripheral nervous system neoplasm	0.000374	0.174	CrCbGaD
Hydrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—NF1—peripheral nervous system neoplasm	0.000365	0.0134	CbGpPWpGaD
Hydrocortisone—NR3C1—AP-1 transcription factor network—NTS—peripheral nervous system neoplasm	0.000347	0.0127	CbGpPWpGaD
Hydrocortisone—SHBG—Nongenotropic Androgen signaling—HRAS—peripheral nervous system neoplasm	0.00034	0.0125	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.000334	0.0122	CbGpPWpGaD
Hydrocortisone—ANXA1—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.000331	0.0122	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—AURKA—peripheral nervous system neoplasm	0.000312	0.0114	CbGpPWpGaD
Hydrocortisone—SHBG—Nongenotropic Androgen signaling—AKT1—peripheral nervous system neoplasm	0.000301	0.011	CbGpPWpGaD
Hydrocortisone—ABCG2—HIF-2-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	0.0003	0.011	CbGpPWpGaD
Hydrocortisone—ANXA1—Spinal Cord Injury—BDNF—peripheral nervous system neoplasm	0.000283	0.0104	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000279	0.0102	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.000252	0.00926	CbGpPWpGaD
Hydrocortisone—CYP3A4—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000251	0.00921	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000242	0.00887	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000231	0.00848	CbGpPWpGaD
Hydrocortisone—Megestrol acetate—ABCB1—peripheral nervous system neoplasm	0.000227	0.106	CrCbGaD
Hydrocortisone—ANXA1—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	0.000225	0.00825	CbGpPWpGaD
Hydrocortisone—ANXA1—Peptide ligand-binding receptors—KNG1—peripheral nervous system neoplasm	0.000222	0.00814	CbGpPWpGaD
Hydrocortisone—CYP11B1—Corticotropin-releasing hormone—GNAS—peripheral nervous system neoplasm	0.000219	0.00805	CbGpPWpGaD
Hydrocortisone—CYP3A4—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000213	0.00782	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.000211	0.00773	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000208	0.00765	CbGpPWpGaD
Hydrocortisone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	0.000201	0.00738	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.000193	0.00708	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.00019	0.00696	CbGpPWpGaD
Hydrocortisone—ANXA1—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	0.000187	0.00687	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.00018	0.00659	CbGpPWpGaD
Hydrocortisone—CYP3A5—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000178	0.00654	CbGpPWpGaD
Hydrocortisone—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—peripheral nervous system neoplasm	0.000177	0.00649	CbGpPWpGaD
Hydrocortisone—ABCG2—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	0.000176	0.00648	CbGpPWpGaD
Hydrocortisone—Methylprednisolone—ABCB1—peripheral nervous system neoplasm	0.000174	0.081	CrCbGaD
Hydrocortisone—NR3C1—AP-1 transcription factor network—TH—peripheral nervous system neoplasm	0.000167	0.00613	CbGpPWpGaD
Hydrocortisone—ANXA1—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	0.000164	0.00601	CbGpPWpGaD
Hydrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IFNB1—peripheral nervous system neoplasm	0.00015	0.00549	CbGpPWpGaD
Hydrocortisone—ANXA1—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000149	0.00546	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000143	0.00523	CbGpPWpGaD
Hydrocortisone—ANXA1—Spinal Cord Injury—CASP3—peripheral nervous system neoplasm	0.000142	0.0052	CbGpPWpGaD
Hydrocortisone—Spironolactone—ABCB1—peripheral nervous system neoplasm	0.000141	0.0657	CrCbGaD
Hydrocortisone—ABCG2—HIF-1-alpha transcription factor network—ABCB1—peripheral nervous system neoplasm	0.000139	0.00511	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000137	0.00504	CbGpPWpGaD
Hydrocortisone—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000137	0.00504	CbGpPWpGaD
Hydrocortisone—Prednisone—ABCB1—peripheral nervous system neoplasm	0.000133	0.0619	CrCbGaD
Hydrocortisone—Norethindrone—ABCB1—peripheral nervous system neoplasm	0.000131	0.061	CrCbGaD
Hydrocortisone—ANXA1—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000129	0.00475	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000124	0.00455	CbGpPWpGaD
Hydrocortisone—Prednisolone—ABCB1—peripheral nervous system neoplasm	0.000123	0.0571	CrCbGaD
Hydrocortisone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	0.000122	0.00448	CbGpPWpGaD
Hydrocortisone—Betamethasone—ABCB1—peripheral nervous system neoplasm	0.00012	0.0559	CrCbGaD
Hydrocortisone—CYP11B1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000118	0.00435	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000116	0.00427	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000113	0.00416	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000113	0.00413	CbGpPWpGaD
Hydrocortisone—ANXA1—Spinal Cord Injury—MYC—peripheral nervous system neoplasm	0.000111	0.00406	CbGpPWpGaD
Hydrocortisone—CYP11B1—Corticotropin-releasing hormone—CASP3—peripheral nervous system neoplasm	0.000109	0.00401	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000108	0.00396	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	0.000106	0.00389	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	9.91e-05	0.00364	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	9.81e-05	0.0036	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	9.63e-05	0.00353	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	9.6e-05	0.00352	CbGpPWpGaD
Hydrocortisone—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	9.54e-05	0.0035	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—HSD17B12—peripheral nervous system neoplasm	9.28e-05	0.00341	CbGpPWpGaD
Hydrocortisone—ANXA1—Spinal Cord Injury—TP53—peripheral nervous system neoplasm	9.08e-05	0.00333	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	9.08e-05	0.00333	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	9.05e-05	0.00332	CbGpPWpGaD
Hydrocortisone—Infection—Cisplatin—peripheral nervous system neoplasm	8.89e-05	0.000403	CcSEcCtD
Hydrocortisone—Vomiting—Topotecan—peripheral nervous system neoplasm	8.89e-05	0.000402	CcSEcCtD
Hydrocortisone—Cardiac failure—Doxorubicin—peripheral nervous system neoplasm	8.87e-05	0.000401	CcSEcCtD
Hydrocortisone—Mood swings—Epirubicin—peripheral nervous system neoplasm	8.86e-05	0.000401	CcSEcCtD
Hydrocortisone—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	8.83e-05	0.0004	CcSEcCtD
Hydrocortisone—Lethargy—Doxorubicin—peripheral nervous system neoplasm	8.83e-05	0.0004	CcSEcCtD
Hydrocortisone—Vomiting—Tretinoin—peripheral nervous system neoplasm	8.82e-05	0.000399	CcSEcCtD
Hydrocortisone—Vomiting—Isotretinoin—peripheral nervous system neoplasm	8.82e-05	0.000399	CcSEcCtD
Hydrocortisone—Rash—Topotecan—peripheral nervous system neoplasm	8.81e-05	0.000399	CcSEcCtD
Hydrocortisone—Dermatitis—Topotecan—peripheral nervous system neoplasm	8.8e-05	0.000399	CcSEcCtD
Hydrocortisone—Decreased appetite—Vincristine—peripheral nervous system neoplasm	8.8e-05	0.000398	CcSEcCtD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	8.8e-05	0.00323	CbGpPWpGaD
Hydrocortisone—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	8.78e-05	0.000397	CcSEcCtD
Hydrocortisone—Headache—Topotecan—peripheral nervous system neoplasm	8.76e-05	0.000396	CcSEcCtD
Hydrocortisone—Rash—Tretinoin—peripheral nervous system neoplasm	8.74e-05	0.000396	CcSEcCtD
Hydrocortisone—Rash—Isotretinoin—peripheral nervous system neoplasm	8.74e-05	0.000396	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	8.74e-05	0.000396	CcSEcCtD
Hydrocortisone—Tachycardia—Cisplatin—peripheral nervous system neoplasm	8.74e-05	0.000396	CcSEcCtD
Hydrocortisone—Dermatitis—Tretinoin—peripheral nervous system neoplasm	8.73e-05	0.000395	CcSEcCtD
Hydrocortisone—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	8.73e-05	0.000395	CcSEcCtD
Hydrocortisone—Fatigue—Vincristine—peripheral nervous system neoplasm	8.73e-05	0.000395	CcSEcCtD
Hydrocortisone—Convulsion—Etoposide—peripheral nervous system neoplasm	8.71e-05	0.000394	CcSEcCtD
Hydrocortisone—Vomiting—Melphalan—peripheral nervous system neoplasm	8.7e-05	0.000394	CcSEcCtD
Hydrocortisone—Skin disorder—Cisplatin—peripheral nervous system neoplasm	8.7e-05	0.000394	CcSEcCtD
Hydrocortisone—Headache—Isotretinoin—peripheral nervous system neoplasm	8.69e-05	0.000393	CcSEcCtD
Hydrocortisone—Headache—Tretinoin—peripheral nervous system neoplasm	8.69e-05	0.000393	CcSEcCtD
Hydrocortisone—Hypertension—Etoposide—peripheral nervous system neoplasm	8.68e-05	0.000393	CcSEcCtD
Hydrocortisone—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	8.66e-05	0.000392	CcSEcCtD
Hydrocortisone—Pain—Vincristine—peripheral nervous system neoplasm	8.66e-05	0.000392	CcSEcCtD
Hydrocortisone—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	8.66e-05	0.000392	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	8.66e-05	0.000392	CcSEcCtD
Hydrocortisone—Rash—Melphalan—peripheral nervous system neoplasm	8.63e-05	0.000391	CcSEcCtD
Hydrocortisone—Dermatitis—Melphalan—peripheral nervous system neoplasm	8.62e-05	0.00039	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	8.59e-05	0.000389	CcSEcCtD
Hydrocortisone—Dry skin—Epirubicin—peripheral nervous system neoplasm	8.57e-05	0.000388	CcSEcCtD
Hydrocortisone—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	8.54e-05	0.000387	CcSEcCtD
Hydrocortisone—Anorexia—Cisplatin—peripheral nervous system neoplasm	8.53e-05	0.000386	CcSEcCtD
Hydrocortisone—Affect lability—Doxorubicin—peripheral nervous system neoplasm	8.52e-05	0.000386	CcSEcCtD
Hydrocortisone—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	8.51e-05	0.000385	CcSEcCtD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	8.5e-05	0.000385	CcSEcCtD
Hydrocortisone—Discomfort—Etoposide—peripheral nervous system neoplasm	8.45e-05	0.000383	CcSEcCtD
Hydrocortisone—Hypotension—Cisplatin—peripheral nervous system neoplasm	8.37e-05	0.000379	CcSEcCtD
Hydrocortisone—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	8.35e-05	0.000378	CcSEcCtD
Hydrocortisone—Urticaria—Alitretinoin—peripheral nervous system neoplasm	8.35e-05	0.000378	CcSEcCtD
Hydrocortisone—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	8.31e-05	0.000376	CcSEcCtD
Hydrocortisone—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	8.31e-05	0.000376	CcSEcCtD
Hydrocortisone—Nausea—Topotecan—peripheral nervous system neoplasm	8.3e-05	0.000376	CcSEcCtD
Hydrocortisone—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	8.28e-05	0.00304	CbGpPWpGaD
Hydrocortisone—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	8.28e-05	0.000375	CcSEcCtD
Hydrocortisone—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	8.25e-05	0.000373	CcSEcCtD
Hydrocortisone—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	8.25e-05	0.000373	CcSEcCtD
Hydrocortisone—Nausea—Tretinoin—peripheral nervous system neoplasm	8.24e-05	0.000373	CcSEcCtD
Hydrocortisone—Nausea—Isotretinoin—peripheral nervous system neoplasm	8.24e-05	0.000373	CcSEcCtD
Hydrocortisone—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	8.23e-05	0.000373	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	8.2e-05	0.000371	CcSEcCtD
Hydrocortisone—Mood swings—Doxorubicin—peripheral nervous system neoplasm	8.2e-05	0.000371	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	8.16e-05	0.000369	CcSEcCtD
Hydrocortisone—Infection—Etoposide—peripheral nervous system neoplasm	8.15e-05	0.000369	CcSEcCtD
Hydrocortisone—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	8.14e-05	0.000368	CcSEcCtD
Hydrocortisone—Asthenia—Dactinomycin—peripheral nervous system neoplasm	8.13e-05	0.000368	CcSEcCtD
Hydrocortisone—Nausea—Melphalan—peripheral nervous system neoplasm	8.13e-05	0.000368	CcSEcCtD
Hydrocortisone—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	8.04e-05	0.000364	CcSEcCtD
Hydrocortisone—Tachycardia—Etoposide—peripheral nervous system neoplasm	8.01e-05	0.000362	CcSEcCtD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	8e-05	0.00294	CbGpPWpGaD
Hydrocortisone—Body temperature increased—Vincristine—peripheral nervous system neoplasm	8e-05	0.000362	CcSEcCtD
Hydrocortisone—Abdominal pain—Vincristine—peripheral nervous system neoplasm	8e-05	0.000362	CcSEcCtD
Hydrocortisone—CYP11B1—Metabolism—HSD17B12—peripheral nervous system neoplasm	8e-05	0.00294	CbGpPWpGaD
Hydrocortisone—Skin disorder—Etoposide—peripheral nervous system neoplasm	7.97e-05	0.000361	CcSEcCtD
Hydrocortisone—Dry skin—Doxorubicin—peripheral nervous system neoplasm	7.93e-05	0.000359	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	7.93e-05	0.000359	CcSEcCtD
Hydrocortisone—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	7.93e-05	0.000359	CcSEcCtD
Hydrocortisone—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	7.91e-05	0.000358	CcSEcCtD
Hydrocortisone—ABCG2—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	7.9e-05	0.0029	CbGpPWpGaD
Hydrocortisone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	7.89e-05	0.0029	CbGpPWpGaD
Hydrocortisone—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	7.88e-05	0.000357	CcSEcCtD
Hydrocortisone—NR3C1—AP-1 transcription factor network—CDKN2A—peripheral nervous system neoplasm	7.83e-05	0.00287	CbGpPWpGaD
Hydrocortisone—Anorexia—Etoposide—peripheral nervous system neoplasm	7.82e-05	0.000354	CcSEcCtD
Hydrocortisone—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	7.78e-05	0.000352	CcSEcCtD
Hydrocortisone—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	7.75e-05	0.000351	CcSEcCtD
Hydrocortisone—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	7.74e-05	0.00035	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	7.73e-05	0.00035	CcSEcCtD
Hydrocortisone—CYP11B2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	7.72e-05	0.00283	CbGpPWpGaD
Hydrocortisone—Hypotension—Etoposide—peripheral nervous system neoplasm	7.66e-05	0.000347	CcSEcCtD
Hydrocortisone—Pain—Cisplatin—peripheral nervous system neoplasm	7.66e-05	0.000347	CcSEcCtD
Hydrocortisone—ANXA1—Signaling Pathways—NTS—peripheral nervous system neoplasm	7.65e-05	0.00281	CbGpPWpGaD
Hydrocortisone—Progesterone—ABCB1—peripheral nervous system neoplasm	7.64e-05	0.0356	CrCbGaD
Hydrocortisone—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	7.63e-05	0.000346	CcSEcCtD
Hydrocortisone—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	7.63e-05	0.000346	CcSEcCtD
Hydrocortisone—Asthenia—Alitretinoin—peripheral nervous system neoplasm	7.54e-05	0.000341	CcSEcCtD
Hydrocortisone—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	7.53e-05	0.000341	CcSEcCtD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	7.52e-05	0.00276	CbGpPWpGaD
Hydrocortisone—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	7.51e-05	0.00034	CcSEcCtD
Hydrocortisone—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	7.46e-05	0.000338	CcSEcCtD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	7.45e-05	0.00274	CbGpPWpGaD
Hydrocortisone—SLCO1A2—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	7.44e-05	0.00273	CbGpPWpGaD
Hydrocortisone—Pruritus—Alitretinoin—peripheral nervous system neoplasm	7.43e-05	0.000337	CcSEcCtD
Hydrocortisone—SLCO1A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	7.43e-05	0.00273	CbGpPWpGaD
Hydrocortisone—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	7.38e-05	0.000334	CcSEcCtD
Hydrocortisone—Paraesthesia—Etoposide—peripheral nervous system neoplasm	7.37e-05	0.000333	CcSEcCtD
Hydrocortisone—Weight increased—Epirubicin—peripheral nervous system neoplasm	7.36e-05	0.000333	CcSEcCtD
Hydrocortisone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	7.34e-05	0.0027	CbGpPWpGaD
Hydrocortisone—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	7.33e-05	0.000332	CcSEcCtD
Hydrocortisone—ANXA1—Signaling Pathways—CD55—peripheral nervous system neoplasm	7.33e-05	0.00269	CbGpPWpGaD
Hydrocortisone—Weight decreased—Epirubicin—peripheral nervous system neoplasm	7.31e-05	0.000331	CcSEcCtD
Hydrocortisone—Asthenia—Vincristine—peripheral nervous system neoplasm	7.26e-05	0.000329	CcSEcCtD
Hydrocortisone—Testosterone—ABCB1—peripheral nervous system neoplasm	7.22e-05	0.0336	CrCbGaD
Hydrocortisone—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	7.21e-05	0.000326	CcSEcCtD
Hydrocortisone—Infestation—Epirubicin—peripheral nervous system neoplasm	7.21e-05	0.000326	CcSEcCtD
Hydrocortisone—Vomiting—Dactinomycin—peripheral nervous system neoplasm	7.21e-05	0.000326	CcSEcCtD
Hydrocortisone—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	7.19e-05	0.000325	CcSEcCtD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	7.16e-05	0.00263	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	7.15e-05	0.00262	CbGpPWpGaD
Hydrocortisone—Rash—Dactinomycin—peripheral nervous system neoplasm	7.15e-05	0.000323	CcSEcCtD
Hydrocortisone—Decreased appetite—Etoposide—peripheral nervous system neoplasm	7.13e-05	0.000323	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	7.08e-05	0.000321	CcSEcCtD
Hydrocortisone—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	7.08e-05	0.00032	CcSEcCtD
Hydrocortisone—Fatigue—Etoposide—peripheral nervous system neoplasm	7.07e-05	0.00032	CcSEcCtD
Hydrocortisone—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	7.07e-05	0.00032	CcSEcCtD
Hydrocortisone—Pain—Etoposide—peripheral nervous system neoplasm	7.01e-05	0.000318	CcSEcCtD
Hydrocortisone—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	7.01e-05	0.00257	CbGpPWpGaD
Hydrocortisone—Dexamethasone—ABCB1—peripheral nervous system neoplasm	6.99e-05	0.0325	CrCbGaD
Hydrocortisone—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	6.95e-05	0.000315	CcSEcCtD
Hydrocortisone—Dizziness—Alitretinoin—peripheral nervous system neoplasm	6.95e-05	0.000315	CcSEcCtD
Hydrocortisone—Diarrhoea—Vincristine—peripheral nervous system neoplasm	6.93e-05	0.000314	CcSEcCtD
Hydrocortisone—Weight increased—Doxorubicin—peripheral nervous system neoplasm	6.81e-05	0.000308	CcSEcCtD
Hydrocortisone—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	6.77e-05	0.000306	CcSEcCtD
Hydrocortisone—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	6.76e-05	0.000306	CcSEcCtD
Hydrocortisone—Nausea—Dactinomycin—peripheral nervous system neoplasm	6.73e-05	0.000305	CcSEcCtD
Hydrocortisone—CYP11B2—Metabolism—GNS—peripheral nervous system neoplasm	6.71e-05	0.00246	CbGpPWpGaD
Hydrocortisone—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	6.71e-05	0.000304	CcSEcCtD
Hydrocortisone—Dizziness—Vincristine—peripheral nervous system neoplasm	6.7e-05	0.000303	CcSEcCtD
Hydrocortisone—Vomiting—Alitretinoin—peripheral nervous system neoplasm	6.68e-05	0.000302	CcSEcCtD
Hydrocortisone—Infestation—Doxorubicin—peripheral nervous system neoplasm	6.67e-05	0.000302	CcSEcCtD
Hydrocortisone—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	6.67e-05	0.000302	CcSEcCtD
Hydrocortisone—CYP11B1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	6.65e-05	0.00244	CbGpPWpGaD
Hydrocortisone—Rash—Alitretinoin—peripheral nervous system neoplasm	6.63e-05	0.0003	CcSEcCtD
Hydrocortisone—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	6.62e-05	0.0003	CcSEcCtD
Hydrocortisone—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	6.6e-05	0.000299	CcSEcCtD
Hydrocortisone—Bradycardia—Epirubicin—peripheral nervous system neoplasm	6.59e-05	0.000298	CcSEcCtD
Hydrocortisone—Headache—Alitretinoin—peripheral nervous system neoplasm	6.58e-05	0.000298	CcSEcCtD
Hydrocortisone—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	6.54e-05	0.000296	CcSEcCtD
Hydrocortisone—Urticaria—Etoposide—peripheral nervous system neoplasm	6.52e-05	0.000295	CcSEcCtD
Hydrocortisone—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	6.5e-05	0.000294	CcSEcCtD
Hydrocortisone—Abdominal pain—Etoposide—peripheral nervous system neoplasm	6.48e-05	0.000294	CcSEcCtD
Hydrocortisone—Body temperature increased—Etoposide—peripheral nervous system neoplasm	6.48e-05	0.000294	CcSEcCtD
Hydrocortisone—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	6.47e-05	0.000293	CcSEcCtD
Hydrocortisone—Vomiting—Vincristine—peripheral nervous system neoplasm	6.44e-05	0.000291	CcSEcCtD
Hydrocortisone—CYP11B2—Metabolism—NME1—peripheral nervous system neoplasm	6.44e-05	0.00236	CbGpPWpGaD
Hydrocortisone—Asthenia—Cisplatin—peripheral nervous system neoplasm	6.42e-05	0.000291	CcSEcCtD
Hydrocortisone—ANXA1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	6.41e-05	0.00235	CbGpPWpGaD
Hydrocortisone—Rash—Vincristine—peripheral nervous system neoplasm	6.38e-05	0.000289	CcSEcCtD
Hydrocortisone—Dermatitis—Vincristine—peripheral nervous system neoplasm	6.38e-05	0.000289	CcSEcCtD
Hydrocortisone—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	6.36e-05	0.000288	CcSEcCtD
Hydrocortisone—Headache—Vincristine—peripheral nervous system neoplasm	6.34e-05	0.000287	CcSEcCtD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	6.29e-05	0.00231	CbGpPWpGaD
Hydrocortisone—Nausea—Alitretinoin—peripheral nervous system neoplasm	6.24e-05	0.000283	CcSEcCtD
Hydrocortisone—CYP11B2—Metabolism—COX2—peripheral nervous system neoplasm	6.19e-05	0.00227	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	6.18e-05	0.00227	CbGpPWpGaD
Hydrocortisone—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	6.13e-05	0.000277	CcSEcCtD
Hydrocortisone—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	6.1e-05	0.000276	CcSEcCtD
Hydrocortisone—Eye disorder—Epirubicin—peripheral nervous system neoplasm	6.05e-05	0.000274	CcSEcCtD
Hydrocortisone—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	6.04e-05	0.000274	CcSEcCtD
Hydrocortisone—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	6.02e-05	0.000272	CcSEcCtD
Hydrocortisone—Nausea—Vincristine—peripheral nervous system neoplasm	6.01e-05	0.000272	CcSEcCtD
Hydrocortisone—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	5.99e-05	0.000271	CcSEcCtD
Hydrocortisone—CYP11B1—Corticotropin-releasing hormone—AKT1—peripheral nervous system neoplasm	5.92e-05	0.00217	CbGpPWpGaD
Hydrocortisone—Asthenia—Etoposide—peripheral nervous system neoplasm	5.88e-05	0.000266	CcSEcCtD
Hydrocortisone—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	5.88e-05	0.000266	CcSEcCtD
Hydrocortisone—ABCG2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.88e-05	0.00216	CbGpPWpGaD
Hydrocortisone—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	5.85e-05	0.000265	CcSEcCtD
Hydrocortisone—CYP3A7—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.83e-05	0.00214	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	5.82e-05	0.00213	CbGpPWpGaD
Hydrocortisone—Pruritus—Etoposide—peripheral nervous system neoplasm	5.8e-05	0.000263	CcSEcCtD
Hydrocortisone—ANXA1—Signaling Pathways—VIP—peripheral nervous system neoplasm	5.8e-05	0.00213	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—GNS—peripheral nervous system neoplasm	5.78e-05	0.00212	CbGpPWpGaD
Hydrocortisone—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	5.78e-05	0.000262	CcSEcCtD
Hydrocortisone—Vomiting—Cisplatin—peripheral nervous system neoplasm	5.69e-05	0.000258	CcSEcCtD
Hydrocortisone—Mental disorder—Epirubicin—peripheral nervous system neoplasm	5.67e-05	0.000257	CcSEcCtD
Hydrocortisone—ABCG2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	5.66e-05	0.00208	CbGpPWpGaD
Hydrocortisone—Rash—Cisplatin—peripheral nervous system neoplasm	5.65e-05	0.000256	CcSEcCtD
Hydrocortisone—Dermatitis—Cisplatin—peripheral nervous system neoplasm	5.64e-05	0.000255	CcSEcCtD
Hydrocortisone—Malnutrition—Epirubicin—peripheral nervous system neoplasm	5.63e-05	0.000255	CcSEcCtD
Hydrocortisone—Erythema—Epirubicin—peripheral nervous system neoplasm	5.63e-05	0.000255	CcSEcCtD
Hydrocortisone—Diarrhoea—Etoposide—peripheral nervous system neoplasm	5.61e-05	0.000254	CcSEcCtD
Hydrocortisone—ANXA1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	5.6e-05	0.00206	CbGpPWpGaD
Hydrocortisone—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	5.6e-05	0.000253	CcSEcCtD
Hydrocortisone—CYP11B1—Metabolism—NME1—peripheral nervous system neoplasm	5.55e-05	0.00204	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	5.54e-05	0.00203	CbGpPWpGaD
Hydrocortisone—Dizziness—Etoposide—peripheral nervous system neoplasm	5.42e-05	0.000246	CcSEcCtD
Hydrocortisone—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	5.41e-05	0.000245	CcSEcCtD
Hydrocortisone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	5.37e-05	0.00197	CbGpPWpGaD
Hydrocortisone—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	5.35e-05	0.000242	CcSEcCtD
Hydrocortisone—ANXA1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	5.35e-05	0.00196	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—COX2—peripheral nervous system neoplasm	5.34e-05	0.00196	CbGpPWpGaD
Hydrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	5.33e-05	0.00196	CbGpPWpGaD
Hydrocortisone—Nausea—Cisplatin—peripheral nervous system neoplasm	5.32e-05	0.000241	CcSEcCtD
Hydrocortisone—NR3C1—AP-1 transcription factor network—MYC—peripheral nervous system neoplasm	5.31e-05	0.00195	CbGpPWpGaD
Hydrocortisone—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	5.25e-05	0.000237	CcSEcCtD
Hydrocortisone—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	5.23e-05	0.000237	CcSEcCtD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	5.22e-05	0.00191	CbGpPWpGaD
Hydrocortisone—Vomiting—Etoposide—peripheral nervous system neoplasm	5.22e-05	0.000236	CcSEcCtD
Hydrocortisone—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	5.21e-05	0.000236	CcSEcCtD
Hydrocortisone—Erythema—Doxorubicin—peripheral nervous system neoplasm	5.21e-05	0.000236	CcSEcCtD
Hydrocortisone—Rash—Etoposide—peripheral nervous system neoplasm	5.17e-05	0.000234	CcSEcCtD
Hydrocortisone—Dermatitis—Etoposide—peripheral nervous system neoplasm	5.17e-05	0.000234	CcSEcCtD
Hydrocortisone—NR3C1—Gene Expression—EED—peripheral nervous system neoplasm	5.14e-05	0.00189	CbGpPWpGaD
Hydrocortisone—Headache—Etoposide—peripheral nervous system neoplasm	5.14e-05	0.000233	CcSEcCtD
Hydrocortisone—ANXA1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	5.09e-05	0.00187	CbGpPWpGaD
Hydrocortisone—Malaise—Epirubicin—peripheral nervous system neoplasm	5.08e-05	0.00023	CcSEcCtD
Hydrocortisone—Vertigo—Epirubicin—peripheral nervous system neoplasm	5.06e-05	0.000229	CcSEcCtD
Hydrocortisone—Syncope—Epirubicin—peripheral nervous system neoplasm	5.05e-05	0.000229	CcSEcCtD
Hydrocortisone—SLCO1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.02e-05	0.00184	CbGpPWpGaD
Hydrocortisone—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	4.95e-05	0.000224	CcSEcCtD
Hydrocortisone—Convulsion—Epirubicin—peripheral nervous system neoplasm	4.88e-05	0.000221	CcSEcCtD
Hydrocortisone—Nausea—Etoposide—peripheral nervous system neoplasm	4.87e-05	0.000221	CcSEcCtD
Hydrocortisone—Hypertension—Epirubicin—peripheral nervous system neoplasm	4.86e-05	0.00022	CcSEcCtD
Hydrocortisone—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	4.84e-05	0.000219	CcSEcCtD
Hydrocortisone—Myalgia—Epirubicin—peripheral nervous system neoplasm	4.8e-05	0.000217	CcSEcCtD
Hydrocortisone—Anxiety—Epirubicin—peripheral nervous system neoplasm	4.78e-05	0.000216	CcSEcCtD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	4.76e-05	0.000216	CcSEcCtD
Hydrocortisone—Discomfort—Epirubicin—peripheral nervous system neoplasm	4.74e-05	0.000215	CcSEcCtD
Hydrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—peripheral nervous system neoplasm	4.72e-05	0.00173	CbGpPWpGaD
Hydrocortisone—Malaise—Doxorubicin—peripheral nervous system neoplasm	4.7e-05	0.000213	CcSEcCtD
Hydrocortisone—Vertigo—Doxorubicin—peripheral nervous system neoplasm	4.68e-05	0.000212	CcSEcCtD
Hydrocortisone—Syncope—Doxorubicin—peripheral nervous system neoplasm	4.67e-05	0.000212	CcSEcCtD
Hydrocortisone—Oedema—Epirubicin—peripheral nervous system neoplasm	4.6e-05	0.000208	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	4.6e-05	0.000208	CcSEcCtD
Hydrocortisone—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	4.58e-05	0.000207	CcSEcCtD
Hydrocortisone—Infection—Epirubicin—peripheral nervous system neoplasm	4.57e-05	0.000207	CcSEcCtD
Hydrocortisone—Shock—Epirubicin—peripheral nervous system neoplasm	4.52e-05	0.000205	CcSEcCtD
Hydrocortisone—Convulsion—Doxorubicin—peripheral nervous system neoplasm	4.52e-05	0.000204	CcSEcCtD
Hydrocortisone—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	4.51e-05	0.000204	CcSEcCtD
Hydrocortisone—Hypertension—Doxorubicin—peripheral nervous system neoplasm	4.5e-05	0.000204	CcSEcCtD
Hydrocortisone—Tachycardia—Epirubicin—peripheral nervous system neoplasm	4.49e-05	0.000203	CcSEcCtD
Hydrocortisone—Skin disorder—Epirubicin—peripheral nervous system neoplasm	4.47e-05	0.000202	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	4.44e-05	0.000201	CcSEcCtD
Hydrocortisone—Myalgia—Doxorubicin—peripheral nervous system neoplasm	4.44e-05	0.000201	CcSEcCtD
Hydrocortisone—Anxiety—Doxorubicin—peripheral nervous system neoplasm	4.42e-05	0.0002	CcSEcCtD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	4.41e-05	0.0002	CcSEcCtD
Hydrocortisone—Discomfort—Doxorubicin—peripheral nervous system neoplasm	4.38e-05	0.000198	CcSEcCtD
Hydrocortisone—Anorexia—Epirubicin—peripheral nervous system neoplasm	4.38e-05	0.000198	CcSEcCtD
Hydrocortisone—NR3C1—AP-1 transcription factor network—TP53—peripheral nervous system neoplasm	4.36e-05	0.0016	CbGpPWpGaD
Hydrocortisone—Hypotension—Epirubicin—peripheral nervous system neoplasm	4.3e-05	0.000194	CcSEcCtD
Hydrocortisone—Oedema—Doxorubicin—peripheral nervous system neoplasm	4.25e-05	0.000193	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	4.25e-05	0.000193	CcSEcCtD
Hydrocortisone—Infection—Doxorubicin—peripheral nervous system neoplasm	4.23e-05	0.000191	CcSEcCtD
Hydrocortisone—CYP3A5—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.21e-05	0.00155	CbGpPWpGaD
Hydrocortisone—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	4.19e-05	0.00019	CcSEcCtD
Hydrocortisone—Shock—Doxorubicin—peripheral nervous system neoplasm	4.19e-05	0.000189	CcSEcCtD
Hydrocortisone—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	4.17e-05	0.000189	CcSEcCtD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.17e-05	0.00153	CbGpPWpGaD
Hydrocortisone—Insomnia—Epirubicin—peripheral nervous system neoplasm	4.16e-05	0.000188	CcSEcCtD
Hydrocortisone—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	4.15e-05	0.000188	CcSEcCtD
Hydrocortisone—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	4.13e-05	0.000187	CcSEcCtD
Hydrocortisone—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	4.13e-05	0.000187	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	4.11e-05	0.000186	CcSEcCtD
Hydrocortisone—NR3C1—Gene Expression—SUZ12—peripheral nervous system neoplasm	4.11e-05	0.00151	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—ENO2—peripheral nervous system neoplasm	4.07e-05	0.00149	CbGpPWpGaD
Hydrocortisone—Anorexia—Doxorubicin—peripheral nervous system neoplasm	4.06e-05	0.000184	CcSEcCtD
Hydrocortisone—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	4.05e-05	0.000183	CcSEcCtD
Hydrocortisone—ANXA1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.02e-05	0.00147	CbGpPWpGaD
Hydrocortisone—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	4e-05	0.000181	CcSEcCtD
Hydrocortisone—Hypotension—Doxorubicin—peripheral nervous system neoplasm	3.98e-05	0.00018	CcSEcCtD
Hydrocortisone—ABCG2—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.97e-05	0.00146	CbGpPWpGaD
Hydrocortisone—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	3.97e-05	0.00018	CcSEcCtD
Hydrocortisone—Fatigue—Epirubicin—peripheral nervous system neoplasm	3.96e-05	0.000179	CcSEcCtD
Hydrocortisone—CYP3A7—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.94e-05	0.00144	CbGpPWpGaD
Hydrocortisone—Pain—Epirubicin—peripheral nervous system neoplasm	3.93e-05	0.000178	CcSEcCtD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	3.92e-05	0.00144	CbGpPWpGaD
Hydrocortisone—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	3.88e-05	0.000175	CcSEcCtD
Hydrocortisone—Insomnia—Doxorubicin—peripheral nervous system neoplasm	3.85e-05	0.000174	CcSEcCtD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—TP53—peripheral nervous system neoplasm	3.84e-05	0.00141	CbGpPWpGaD
Hydrocortisone—ABCG2—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	3.83e-05	0.00141	CbGpPWpGaD
Hydrocortisone—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	3.82e-05	0.000173	CcSEcCtD
Hydrocortisone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	3.79e-05	0.00139	CbGpPWpGaD
Hydrocortisone—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	3.79e-05	0.000172	CcSEcCtD
Hydrocortisone—SLCO1A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.78e-05	0.00139	CbGpPWpGaD
Hydrocortisone—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	3.76e-05	0.00017	CcSEcCtD
Hydrocortisone—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	3.74e-05	0.00017	CcSEcCtD
Hydrocortisone—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	3.7e-05	0.000167	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	3.67e-05	0.000166	CcSEcCtD
Hydrocortisone—Fatigue—Doxorubicin—peripheral nervous system neoplasm	3.67e-05	0.000166	CcSEcCtD
Hydrocortisone—Urticaria—Epirubicin—peripheral nervous system neoplasm	3.65e-05	0.000165	CcSEcCtD
Hydrocortisone—CYP2C8—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.65e-05	0.00134	CbGpPWpGaD
Hydrocortisone—Pain—Doxorubicin—peripheral nervous system neoplasm	3.64e-05	0.000165	CcSEcCtD
Hydrocortisone—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	3.63e-05	0.000165	CcSEcCtD
Hydrocortisone—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	3.63e-05	0.000165	CcSEcCtD
Hydrocortisone—SLCO1A2—Metabolism—GNS—peripheral nervous system neoplasm	3.63e-05	0.00133	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	3.58e-05	0.00131	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	3.58e-05	0.00131	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.53e-05	0.0013	CbGpPWpGaD
Hydrocortisone—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	3.51e-05	0.000159	CcSEcCtD
Hydrocortisone—CYP11B1—Metabolism—ENO2—peripheral nervous system neoplasm	3.5e-05	0.00129	CbGpPWpGaD
Hydrocortisone—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	3.48e-05	0.000157	CcSEcCtD
Hydrocortisone—SLCO1A2—Metabolism—NME1—peripheral nervous system neoplasm	3.48e-05	0.00128	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—BCHE—peripheral nervous system neoplasm	3.44e-05	0.00126	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.44e-05	0.00126	CbGpPWpGaD
Hydrocortisone—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	3.39e-05	0.000153	CcSEcCtD
Hydrocortisone—Urticaria—Doxorubicin—peripheral nervous system neoplasm	3.38e-05	0.000153	CcSEcCtD
Hydrocortisone—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	3.36e-05	0.000152	CcSEcCtD
Hydrocortisone—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	3.36e-05	0.000152	CcSEcCtD
Hydrocortisone—SLCO1A2—Metabolism—COX2—peripheral nervous system neoplasm	3.35e-05	0.00123	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	3.31e-05	0.00122	CbGpPWpGaD
Hydrocortisone—Asthenia—Epirubicin—peripheral nervous system neoplasm	3.3e-05	0.000149	CcSEcCtD
Hydrocortisone—CYP11B2—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.28e-05	0.0012	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.27e-05	0.0012	CbGpPWpGaD
Hydrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—peripheral nervous system neoplasm	3.27e-05	0.0012	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	3.27e-05	0.0012	CbGpPWpGaD
Hydrocortisone—Pruritus—Epirubicin—peripheral nervous system neoplasm	3.25e-05	0.000147	CcSEcCtD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—peripheral nervous system neoplasm	3.24e-05	0.00119	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—TH—peripheral nervous system neoplasm	3.23e-05	0.00119	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.18e-05	0.00117	CbGpPWpGaD
Hydrocortisone—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	3.15e-05	0.000142	CcSEcCtD
Hydrocortisone—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	3.13e-05	0.000142	CcSEcCtD
Hydrocortisone—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3.06e-05	0.00112	CbGpPWpGaD
Hydrocortisone—Asthenia—Doxorubicin—peripheral nervous system neoplasm	3.05e-05	0.000138	CcSEcCtD
Hydrocortisone—SLCO1A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.04e-05	0.00112	CbGpPWpGaD
Hydrocortisone—Dizziness—Epirubicin—peripheral nervous system neoplasm	3.04e-05	0.000138	CcSEcCtD
Hydrocortisone—Pruritus—Doxorubicin—peripheral nervous system neoplasm	3.01e-05	0.000136	CcSEcCtD
Hydrocortisone—ANXA1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3e-05	0.0011	CbGpPWpGaD
Hydrocortisone—ABCG2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.99e-05	0.0011	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.99e-05	0.0011	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—BCHE—peripheral nervous system neoplasm	2.96e-05	0.00109	CbGpPWpGaD
Hydrocortisone—Vomiting—Epirubicin—peripheral nervous system neoplasm	2.92e-05	0.000132	CcSEcCtD
Hydrocortisone—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	2.91e-05	0.000132	CcSEcCtD
Hydrocortisone—Rash—Epirubicin—peripheral nervous system neoplasm	2.9e-05	0.000131	CcSEcCtD
Hydrocortisone—Dermatitis—Epirubicin—peripheral nervous system neoplasm	2.9e-05	0.000131	CcSEcCtD
Hydrocortisone—Headache—Epirubicin—peripheral nervous system neoplasm	2.88e-05	0.00013	CcSEcCtD
Hydrocortisone—ABCG2—Metabolism—GNS—peripheral nervous system neoplasm	2.87e-05	0.00105	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—GNS—peripheral nervous system neoplasm	2.85e-05	0.00104	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.85e-05	0.00104	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.82e-05	0.00104	CbGpPWpGaD
Hydrocortisone—Dizziness—Doxorubicin—peripheral nervous system neoplasm	2.81e-05	0.000127	CcSEcCtD
Hydrocortisone—CYP11B1—Metabolism—TH—peripheral nervous system neoplasm	2.78e-05	0.00102	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—NME1—peripheral nervous system neoplasm	2.75e-05	0.00101	CbGpPWpGaD
Hydrocortisone—Nausea—Epirubicin—peripheral nervous system neoplasm	2.73e-05	0.000124	CcSEcCtD
Hydrocortisone—CYP3A7—Metabolism—NME1—peripheral nervous system neoplasm	2.73e-05	0.001	CbGpPWpGaD
Hydrocortisone—Vomiting—Doxorubicin—peripheral nervous system neoplasm	2.7e-05	0.000122	CcSEcCtD
Hydrocortisone—Rash—Doxorubicin—peripheral nervous system neoplasm	2.68e-05	0.000121	CcSEcCtD
Hydrocortisone—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	2.68e-05	0.000121	CcSEcCtD
Hydrocortisone—Headache—Doxorubicin—peripheral nervous system neoplasm	2.67e-05	0.000121	CcSEcCtD
Hydrocortisone—ABCG2—Metabolism—COX2—peripheral nervous system neoplasm	2.65e-05	0.000973	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—GNAS—peripheral nervous system neoplasm	2.64e-05	0.000968	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—COX2—peripheral nervous system neoplasm	2.63e-05	0.000964	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—ABCB1—peripheral nervous system neoplasm	2.59e-05	0.00095	CbGpPWpGaD
Hydrocortisone—Nausea—Doxorubicin—peripheral nervous system neoplasm	2.53e-05	0.000114	CcSEcCtD
Hydrocortisone—CYP2C8—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.47e-05	0.000905	CbGpPWpGaD
Hydrocortisone—ABCG2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.41e-05	0.000884	CbGpPWpGaD
Hydrocortisone—ABCG2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.36e-05	0.000868	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—GNAS—peripheral nervous system neoplasm	2.27e-05	0.000834	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—ABCB1—peripheral nervous system neoplasm	2.23e-05	0.000818	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—ENO2—peripheral nervous system neoplasm	2.2e-05	0.000806	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.15e-05	0.000788	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.13e-05	0.00078	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.09e-05	0.000766	CbGpPWpGaD
Hydrocortisone—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	2.07e-05	0.00076	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—GNS—peripheral nervous system neoplasm	2.06e-05	0.000755	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.05e-05	0.000752	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—NME1—peripheral nervous system neoplasm	1.97e-05	0.000724	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.96e-05	0.000719	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—COX2—peripheral nervous system neoplasm	1.9e-05	0.000697	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—BCHE—peripheral nervous system neoplasm	1.86e-05	0.000681	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.8e-05	0.000661	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—GNS—peripheral nervous system neoplasm	1.78e-05	0.000654	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.77e-05	0.00065	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—TH—peripheral nervous system neoplasm	1.75e-05	0.000641	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—ENO2—peripheral nervous system neoplasm	1.74e-05	0.000639	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—ENO2—peripheral nervous system neoplasm	1.72e-05	0.000633	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—NME1—peripheral nervous system neoplasm	1.71e-05	0.000627	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.65e-05	0.000606	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—COX2—peripheral nervous system neoplasm	1.64e-05	0.000604	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.64e-05	0.0006	CbGpPWpGaD
Hydrocortisone—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.62e-05	0.000594	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.55e-05	0.000571	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	1.55e-05	0.00057	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.51e-05	0.000555	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.5e-05	0.00055	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	1.49e-05	0.000546	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—BCHE—peripheral nervous system neoplasm	1.47e-05	0.00054	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—BCHE—peripheral nervous system neoplasm	1.46e-05	0.000535	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	1.43e-05	0.000526	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—GNAS—peripheral nervous system neoplasm	1.43e-05	0.000523	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.4e-05	0.000515	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.4e-05	0.000513	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.39e-05	0.00051	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—TH—peripheral nervous system neoplasm	1.38e-05	0.000507	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.37e-05	0.000504	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—TH—peripheral nervous system neoplasm	1.37e-05	0.000503	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.32e-05	0.000486	CbGpPWpGaD
Hydrocortisone—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.3e-05	0.000478	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	1.28e-05	0.000469	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.26e-05	0.000461	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—ENO2—peripheral nervous system neoplasm	1.25e-05	0.000457	CbGpPWpGaD
Hydrocortisone—NR3C1—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	1.18e-05	0.000433	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.17e-05	0.000429	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—GNAS—peripheral nervous system neoplasm	1.13e-05	0.000414	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—GNAS—peripheral nervous system neoplasm	1.12e-05	0.00041	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.11e-05	0.000406	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—ABCB1—peripheral nervous system neoplasm	1.1e-05	0.000403	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—ENO2—peripheral nervous system neoplasm	1.08e-05	0.000396	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—BCHE—peripheral nervous system neoplasm	1.05e-05	0.000387	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	1.05e-05	0.000385	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	1e-05	0.000369	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—TH—peripheral nervous system neoplasm	9.9e-06	0.000363	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—TP53—peripheral nervous system neoplasm	9.6e-06	0.000352	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	9.57e-06	0.000351	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	9.41e-06	0.000345	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	9.18e-06	0.000337	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	9.17e-06	0.000337	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—BCHE—peripheral nervous system neoplasm	9.12e-06	0.000335	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	8.85e-06	0.000325	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	8.83e-06	0.000324	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.7e-06	0.000319	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—TH—peripheral nervous system neoplasm	8.58e-06	0.000315	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.11e-06	0.000298	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	8.08e-06	0.000297	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	7.95e-06	0.000292	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	7.93e-06	0.000291	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.58e-06	0.000278	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	7.47e-06	0.000274	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—AKT1—peripheral nervous system neoplasm	7.12e-06	0.000261	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	7e-06	0.000257	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	6.87e-06	0.000252	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—AKT1—peripheral nervous system neoplasm	6.13e-06	0.000225	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	6.1e-06	0.000224	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	5.8e-06	0.000213	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—MYC—peripheral nervous system neoplasm	5.68e-06	0.000209	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	4.9e-06	0.00018	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.67e-06	0.000171	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	4.6e-06	0.000169	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—AKT1—peripheral nervous system neoplasm	3.94e-06	0.000145	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—AKT1—peripheral nervous system neoplasm	3.85e-06	0.000141	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	3.76e-06	0.000138	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	3.69e-06	0.000135	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—AKT1—peripheral nervous system neoplasm	3.05e-06	0.000112	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—AKT1—peripheral nervous system neoplasm	3.02e-06	0.000111	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	2.18e-06	8.01e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	1.89e-06	6.94e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	1.65e-06	6.04e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	1.01e-06	3.72e-05	CbGpPWpGaD
